Author

Yi Peng

Case Comprehensive Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Chen WuiD· 1 shared Chun-Peng Pai· 1 shared Donald Patrick McDonnelliD· 1 shared Han Wang· 1 shared Hung‐Ying KaoiD· 1 shared Jiangan Yue· 1 shared Kristen L. Weber-BonkiD· 1 shared Lisheng GengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chen WuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mitoxantrone inhibits and downregulates ERα through binding at the DBD-LBD interface

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang, Yi Peng, Zixi Yun, Xinyue Li, Chen Wu, Zhenghao Liu, Kristen L. Weber-Bonk, Chun-Peng Pai, Yuan Cao, Jiangan Yue, Sunghee Park, Ruth A. Keri, , Sichun Yang

This study shows mitoxantrone inhibits ERα by binding at the DBD-LBD interface, causing conformational changes and degradation, and effectively targets ER mutations resistant to current therapies.

Molecular Cancer Therapeutics · Sep 10, 2025Peer-reviewedCancer Biology